149 related articles for article (PubMed ID: 33803861)
21. Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET.
Elmenhorst D; Meyer PT; Matusch A; Winz OH; Bauer A
J Nucl Med; 2012 Nov; 53(11):1723-9. PubMed ID: 22966134
[TBL] [Abstract][Full Text] [Related]
22. Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data.
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bauer A; Bier D
Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 31013984
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A
Elmenhorst EM; Elmenhorst D; Benderoth S; Kroll T; Bauer A; Aeschbach D
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8009-8014. PubMed ID: 30012607
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
25. 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Novellino E; Greco G; Lavecchia A; Trincavelli L; Martini C
J Med Chem; 2001 Feb; 44(3):316-27. PubMed ID: 11462973
[TBL] [Abstract][Full Text] [Related]
26. Identification of new potent A
Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J
Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793
[TBL] [Abstract][Full Text] [Related]
27. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.
Bauer A; Holschbach MH; Meyer PT; Boy C; Herzog H; Olsson RA; Coenen HH; Zilles K
Neuroimage; 2003 Aug; 19(4):1760-9. PubMed ID: 12948730
[TBL] [Abstract][Full Text] [Related]
28. Recovery sleep after extended wakefulness restores elevated A
Elmenhorst D; Elmenhorst EM; Hennecke E; Kroll T; Matusch A; Aeschbach D; Bauer A
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4243-4248. PubMed ID: 28373571
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
30. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
Scammells PJ; Baker SP; Belardinelli L; Olsson RA
J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
[TBL] [Abstract][Full Text] [Related]
31. Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis.
Pingle SC; Mishra S; Marcuzzi A; Bhat SG; Sekino Y; Rybak LP; Ramkumar V
J Biol Chem; 2004 Oct; 279(41):43157-67. PubMed ID: 15272017
[TBL] [Abstract][Full Text] [Related]
32. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
Longabaugh JP; Didsbury J; Spiegel A; Stiles GL
Mol Pharmacol; 1989 Nov; 36(5):681-8. PubMed ID: 2511426
[TBL] [Abstract][Full Text] [Related]
33. N-[
Schmitt S; Delamare J; Tirel O; Fillesoye F; Dhilly M; Perrio C
Nucl Med Biol; 2017 Jan; 44():50-61. PubMed ID: 27821345
[TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
35. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3-iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT.
Sihver W; Holschbach MH; Bier D; Wutz W; Schulze A; Olsson RA; Coenen HH
Nucl Med Biol; 2003 Aug; 30(6):661-8. PubMed ID: 12900292
[TBL] [Abstract][Full Text] [Related]
37. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
38. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C
J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625
[TBL] [Abstract][Full Text] [Related]
39. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
[TBL] [Abstract][Full Text] [Related]
40. Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography.
Ishiwata K; Nariai T; Kimura Y; Oda K; Kawamura K; Ishii K; Senda M; Wakabayashi S; Shimada J
Ann Nucl Med; 2002 Sep; 16(6):377-82. PubMed ID: 12416575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
